The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) announced that vaccine providers should resume using the Johnson & Johnson vaccine, and that the benefits of the vaccine outweigh the risks.
The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) announced that vaccine providers should resume using the Johnson & Johnson vaccine, and a review of all available data about the Johnson & Johnson vaccine indicate that the benefits of the vaccine outweigh the risks. The Colorado Department of Public Health and Environment (CDPHE) and the Colorado Joint Vaccine Task Force are alerting providers they can proceed with using the Johnson & Johnson COVID-19 vaccine immediately.
What do you need to know about receiving the Johnson & Johnson vaccine?
- If you get the Johnson & Johnson vaccine in Colorado, you will receive the FDA’s updated warning to patients about the increased risk of very rare but potentially severe thrombosis with thrombocytopenia syndrome (TTS).
- TTS is very rare, but more common in women under the age of 50 (approximately 7 cases of TTS per 1,000,000 vaccine doses have been identified in this group to date).
- The use of the vaccine was paused to further inform health care providers about the possible risk of TTS. Health care providers have now received information on how to identify and treat TTS in the very rare case it were to occur.
No vaccine is recommended over another. All three COVID-19 vaccines are safe, effective, and free.